Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

BICO Group

19.88 SEK

+1.38 %

Less than 1K followers

BICO

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+1.38 %
-16.82 %
-16.47 %
-46.12 %
-37.91 %
-35.66 %
-74.20 %
-90.23 %
+45.91 %

BICO Group operates in the biotechnology industry and focuses on the development and manufacturing of technologies for cell-based research and medical development. The company's products are aimed at researchers and pharmaceutical companies. The business is global with a main presence in Europe, North America and Asia. BICO Group was founded in 2016 and is headquartered in Gothenburg, Sweden.

Read more
Market cap
1.4B SEK
Turnover
2.46M SEK
Revenue
1.95B
EBIT %
-14.85 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
18/2
2026

Annual report '25

29/4
2026

Interim report Q1'26

7/5
2026

General meeting '26

All
Webcasts
Press releases
ShowingAll content types
Regulatory press release12/2/2025, 1:49 PM

Finansinspektionen: Flaggningsmeddelande i BICO Group AB

BICO Group
Regulatory press release12/2/2025, 1:43 PM

Finansinspektionen: Flaggningsmeddelande i BICO Group AB

BICO Group
Regulatory press release12/1/2025, 12:51 PM

Finansinspektionen: Flaggningsmeddelande i BICO Group AB

BICO Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release11/14/2025, 11:34 AM

Redeye: BICO (Q3 Review) - A return to organic growth and adjusted EBITDA profitability

BICO Group
BICO, Audiocast, Q3'25
Webcast11/4/2025, 9:00 AM

BICO, Audiocast, Q3'25

BICO Group
Regulatory press release11/4/2025, 6:00 AM

Publication of BICO Group AB: Interim report Q3 2025

BICO Group
Regulatory press release11/4/2025, 6:00 AM

Publicering av BICO Group AB: Delårsrapport Q3 2025

BICO Group
Regulatory press release11/3/2025, 5:01 PM

BICO lämnar preliminära siffror för Q3 2025 och meddelar nedskrivning

BICO Group
Regulatory press release11/3/2025, 5:01 PM

BICO provides preliminary figures for Q3 2025 and announces impairment

BICO Group
Press release10/21/2025, 5:00 AM

Inbjudan till presentation av BICOs delårsrapport Q3 2025

BICO Group
Press release10/21/2025, 5:00 AM

Invitation to the presentation of BICO’s Interim report Q3 2025

BICO Group
Regulatory press release10/10/2025, 5:00 AM

Valberedning för BICO Group AB inför årsstämman 2026

BICO Group
Regulatory press release10/10/2025, 5:00 AM

BICO Group AB’s Nomination Committee for the 2026 Annual General Meeting

BICO Group
Regulatory press release10/1/2025, 12:12 PM

Finansinspektionen: Flaggningsmeddelande i BICO Group AB

BICO Group
Regulatory press release9/16/2025, 4:28 PM

Maria Rankka utsedd till styrelseordförande i BICO Group AB

BICO Group
Regulatory press release9/16/2025, 4:28 PM

Maria Rankka appointed Board Chair of BICO Group AB

BICO Group
Press release9/15/2025, 5:00 AM

Fraser McLeod utsedd till VD för BICO-företaget Biosero

BICO Group
Press release9/15/2025, 5:00 AM

Fraser McLeod appointed as Managing Director of BICO company Biosero

BICO Group
Regulatory press release9/4/2025, 10:05 PM

BICO-företaget Biosero kommer att leverera laboratorieautomationslösningar till ett värde av 15,2 MUSD

BICO Group
Regulatory press release9/4/2025, 10:05 PM

BICO company Biosero to develop integrated lab automation solutions to a value of 15.2 MUSD

BICO Group
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.